Skip to content
Search

Latest Stories

UK to supply millions of PPE to frontline healthcare staff

Millions of personal protection equipment (PPE) will be delivered to frontline health and social care workers treating coronavirus patients, the government has said.

More visors, aprons and gowns will be manufactured and delivered to the frontline staff in response to the government’s 'call to arms'.


Four new partnerships have been struck to rapidly produce and deliver PPE to frontline workers in the near future, a government communication has said.

Photocentric will supply over 7.6 million protective visors over the next six months, with plans to scale up to making 500,000 visors a day, if required.

Ramfoam has been scheduled to distribute three million visors to the NHS per week. The company is recruiting an additional 100 staff to ensure demand is met, scaling up to over 160.

Starting from this week, Elite Plastics Ltd will deliver 20 million PPE to the NHS and social care sector a month

Macdonald and Taylor Healthcare Ltd, who have scaled up production of isolation gowns and scrubs, so far delivering 40,000 gowns a week for the last two months. They will now be providing an additional 50,000 gowns a week with government fabric for the next six months.

Lord Paul Deighton, adviser to the Health Secretary on PPE, said: “We have already struck deals with around 30 UK companies to manufacture PPE and over 100 suppliers to deliver items at scale and pace. We will continue to identify further opportunities to get more PPE to the frontline rapidly.”

The government said it has delivered over 1.65 billion pieces of PPE to the frontline and deals have already been struck with around 30 companies, including Amazon, Royal Mail, and Jaguar Land Rover, through the “make” initiative to produce much-needed PPE.

The government is also working with over 100 new suppliers to deliver at the scale and pace the UK requires.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less